1. Background and development of the RIGHT-TCM {#sec0005}
==============================================

Reporting quality is a significant part of the study of clinical guidelines. High-quality reports can fully explain the guideline development process and provide useful and clear recommendations for readers. To solve the reporting problem of guidelines, researchers from different countries studied extensively and presented relevant reporting standards. In 1993, a nine-item reporting standard was developed for the summary of clinical practice guidelines (CPGs), which is the first time to provide a template and basis for how to systematically and normatively report the information about the development and content of guidelines \[[@bib0015]\]. In 2003, the Conference on Guideline Standardization (COGS) Working Group was established to develop a reporting standard for CPGs \[[@bib0020]\]. The COGS standard consists of 18 items that cover the entire process of guideline development, but it is limited to the clinical field and has not been updated since 2003. Since the launch of Appraisal of Guidelines for Research and Evaluation II (AGREE II) in 2009, AGREE II has been widely used in the quality evaluation of guidelines \[[@bib0025], [@bib0030], [@bib0035]\]. Although it is stated in the statement that it can also be used as a reporting standard, researchers still generally use it as a quality evaluation tool. In 2016, the international RIGHT Working Group developed the RIGHT Statement as a reporting tool for practice guidelines \[[@bib0040]\]. Based on the World Health Organization guidelines and the items of the COGS and AGREE II, this international reporting tool was developed in strict accordance with existing framework and the Enhancing the QUAlity and Transparency Of health Research (EQUATOR) network approach. Consisting of 22 items across 7 domains, the RIGHT Statement has been widely applied to clinical practice, public health and health policy guidelines \[[@bib0045], [@bib0050], [@bib0055]\].

However, we found the RIGHT Statement checklist does not fully applicable to the traditional Chinese medicine guidelines and hard to reflect its major characteristics \[[@bib0060]\]. TCM is one of the oldest medical systems in the world and its theoretical system has unique characteristics of Chinese culture and philosophy and has accumulated rich clinical experience \[[@bib0065]\]. For example, TCM is characterized by the concept of organic wholeness and treatment based on syndrome differentiation. Its guidelines also reflect its distinctive characteristics and Chinese traditional cultural characteristics. These factors may be ignored in the process of developing and reporting guidelines \[[@bib0070]\]. The reporting standard of the TCM guidelines should reflect the characteristics of Chinese medicine itself. This idea was also endorsed by the RIGHT Working Group, and a multidisciplinary expert was organized to develop the extended version.

The EQUATOR network approach was used as the methodological guidance for this research \[[@bib0075]\], which included in the following three steps: (1) establishment of research working group, (2) systematic review of the literature and items establishment, (3) expert consensus and items selection. Full search strategies are presented in Additional file 1. Conflict of interest and basic characteristics of the expert consensus group are presented in Additional file 2 and Additional file 3, respectively. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) grid rules were used to reach decisions when the consensus is elusive (Additional file 4) \[[@bib0080],[@bib0085]\]. More details of material and methods is presented in Additional file 5.

2. Seven strong recommendation sub-items were determined as extension items into the RIGHT-TCM after two-round online Delphi expert consensus {#sec0010}
=============================================================================================================================================

2.1. Literature search and reporting quality evaluation {#sec0015}
-------------------------------------------------------

The diagram of the screening process is shown in [Fig. 1](#fig0005){ref-type="fig"} . After screened for potentially eligible CPGs, a total of 539 TCM CPGs were eventually included (Additional file 6). Our previous research results showed that the reporting quality of these 539 TCM CPGs was improving, but the overall quality remained suboptimal \[[@bib0060]\]. There were some difficulties we encountered during the evaluation of the TCM guidelines when using the RIGHT Statement. For example, in the background section, TCM have their own unique historical evolution. In terms of epidemiology, there is a lack of statistics on the basic epidemiology of the health problem of TCM. In terms of recommendations, there is a lack of reporting content concerning principle-method-recipe-medicines of TCM. In terms of evidence, there is no uniform reporting standard for the quality of evidence of ancient classic theoretical Chinese medical case and famous experts experience. For these aspects, the existing RIGHT Statement items are not well applicable for TCM.Fig. 1The diagram of the screening process.Fig. 1

2.2. Establishment of items {#sec0020}
---------------------------

After extracting the information of these 539 TCM guidelines, the contents of 10 items were found not included in the RIGHT statement checklist. These items are reported to varying degrees in the TCM guidelines ([Fig. 2](#fig0010){ref-type="fig"} ). Among of them, items 8, 9 and 10 (traditional Chinese medicine decoction, traditional Chinese patent medicine and acupuncture) are the contents often mentioned in interventions section of TCM guidelines. As shown in [Fig. 3](#fig0015){ref-type="fig"} , the specific reporting content of these three items were further analyzed. After discussion in the face-to-face meeting, the core working group determined 24 initial sub-items based on the results of [Fig. 2](#fig0010){ref-type="fig"}, [Fig. 3](#fig0015){ref-type="fig"}. At the same time, one sub-item was supplemented by brainstorming, and finally 25 initial sub-items were formed for expert consensus.Fig. 2The reporting items of TCM guidelines not included in the RIGHT statement\* 1: Identify as a clinical guideline for traditional Chinese medicine through the title.2 : Describe the knowledge of disease based on biomedical theory and/or traditional Chinese medicine theory.3: Describe the basis for diagnosing the disease based on biomedical theory and/or traditional Chinese medicine theory.4: Describe the knowledge of disease pathogenesis in traditional Chinese medicine theory.5: Describe the specific reasons for using traditional Chinese medicine to treat the disease.6: Describe the principle and method of treatment for traditional Chinese medicine in the recommendations.7: Describe whether to treat disease based on the syndrome differentiation of traditional Chinese medicine.8: Provide clear and accurate description of traditional Chinese medicine decoction in the intervention.9: Provide clear and accurate description of traditional Chinese patent medicine in interventions.10: Provide clear and accurate description of the acupuncture in the intervention.Fig. 2Fig. 3The specific reporting content in interventions section of TCM guidelines.Fig. 3

2.3. Expert Consensus {#sec0025}
---------------------

In two-round online consensus Delphi survey, 17 experts were invited into the expert consensus group to conduct consensus, selection and recommendation of items. With profound experience in guideline development, these experts from different research fields are regionally representative, and more than half of them have senior professional title (Additional file 3). All experts were asked to disclose any conflicts of interest before the Delphi technique-based consensus, and they declared no conflict of interest in this research (Additional file 2). The response rate for all 2 rounds of surveys was 100%. (1) First round Delphi consensus. Based on previous work, the 10 initial extension items included a total of 25 sub-items in the basic information, background and recommendations section. After the first round of expert consensus, there were 4 sub-items (item 7, 8, 10 and 10-1) with a consensus degree of ≥70% in "very important" option, which have reached the strong recommendation (Additional file 7). After discussion the first round Delphi consensus results, these 4 sub-items were considered to have reached consensus, and the other 21 items required into the second round of Delphi consensus. (2) Second round Delphi consensus. As shown in Additional file 8, there were 3 sub-items (item 1, 6, and 8-5) with a consensus degree of ≥70% in "very important" option, which have reached the strong recommendation. In addition, 16 sub-items were considered as weak recommendation, while 2 sub-items have been excluded because they have not reached any recommendations in the consensus.

2.4. Item formation {#sec0030}
-------------------

After two-round online Delphi consensus, there were a total of 7 strongly recommended sub-items (S1, S2, S3, S4, S4-1, S5 and S5-1) as extension items into the basic information and recommendations section of the RIGHT-TCM (Additional file 9). S1: Identify as a clinical guideline for traditional Chinese medicine through the title. S2: Describe the principle and method of treatment for traditional Chinese medicine in the recommendations. S3: Describe whether to treat disease based on the syndrome differentiation of traditional Chinese medicine. S4: Provide clear and accurate description of traditional Chinese medicine decoction in the intervention. S4-1: Describe the administration route (e.g., oral, topical), frequency of traditional Chinese medicine decoction. S5: Provide clear and accurate description of the acupuncture in the intervention. S5-1: Describe the acupuncture points, major points, matching points, and their addition and subtraction information. Besides, other 16 weak recommendation sub-items were not included, but these items could be served as a reference for future research ([Table 1](#tbl0005){ref-type="table"} ).Table 1Results after two-round expert consensus.Table 1NumberItemRecommended strengthRemarks1Identify as a clinical guideline for traditional Chinese medicine through the title.**Strong recommendation**Extension of RIGHT 1a item (basic information section)2Describe the knowledge of disease based on biomedical theory and/or traditional Chinese medicine theory.Weak recommendationExtension to the RIGHT background section3Describe the basis for diagnosing the disease based on biomedical theory and/or traditional Chinese medicine theory.Weak recommendation4Describe the knowledge of disease pathogenesis in traditional Chinese medicine theory.Weak recommendation5Describe the specific reasons for using traditional Chinese medicine to treat the disease.Weak recommendation6Describe the principle and method of treatment for traditional Chinese medicine in the recommendations.**Strong recommendation**Extension of RIGHT 13a item (recommendation section)7Describe whether to treat disease based on the syndrome differentiation of traditional Chinese medicine.**Strong recommendation**8Provide clear and accurate description of traditional Chinese medicine decoction in the intervention.**Strong recommendation**8-1Describe the name and provenance of traditional Chinese medicine decoction.Weak recommendation8-2Describe the herbal names, herbal addition and subtraction, dosage of traditional Chinese medicine decoction.Weak recommendation8-3Describe the composition principle, basis and interpretation of traditional Chinese medicine decoction.No recommendation8-4Describe the decocting method of traditional Chinese medicine decoction.Weak recommendation8-5Describe the administration route (e.g., oral, topical), frequency of traditional Chinese medicine decoction.**Strong recommendation**8-6Describe the duration of treatment of traditional Chinese medicine decoction.Weak recommendation9Provide clear and accurate description of traditional Chinese patent medicine in interventions.Weak recommendation9-1Describe the product name (e.g., the trade name), provenance and manufacturer of traditional Chinese patent medicine.No recommendation9-2Describe the dosage of traditional Chinese patent medicine.Weak recommendation9-3Describe the administration route (e.g., oral, topical), frequency of traditional Chinese patent medicine.Weak recommendation9-4Describe the duration of treatment of traditional Chinese patent medicines.Weak recommendation10Provide clear and accurate description of the acupuncture in the intervention.**Strong recommendation**10-1Describe the acupuncture points, major points, matching points, and their addition and subtraction information.**Strong recommendation**10-2Describe the specific information of the needling instrument used in the acupuncture process.Weak recommendation10-3Describe the needling manipulation, needling depth and needling retention time of treatment required for acupuncture.Weak recommendation10-4Describe the frequency of treatment required for acupuncture.Weak recommendation10-5Describe the duration of treatment required for acupuncture.Weak recommendation

3. Explanation and discussion about the RIGHT-TCM {#sec0035}
=================================================

The present paper describes a multi-staged development process of the RIGHT-TCM, including systematic review, reporting quality evaluation and online Delphi expert consensus. Seven strong recommendation sub-items were added on the basis of RIGHT Statement into the basic information and recommendations section. Consistent with the purpose of the RIGHT statement, the RIGHT-TCM can provide an instrument for improving the reporting quality of TCM guidelines and facilitate the target audience to quickly grasp the specific content of the guidelines. The RIGHT-TCM can not only improve the scientificity and transparency, but also reduce the risk of bias in the development process of the CPGs.

One of the purposes of a systematic evaluation is to reduce random errors and systematic errors as much as possible through comprehensive searches and rigorous review and to provide near-real scientific evidence for decision makers \[[@bib0090],[@bib0095]\]. We have comprehensively collected the published CPGs for TCM and tried to use existing tools for evaluation. To begin with, we evaluated the reporting quality of TCM guidelines. The results show that the reporting quality of the TCM guidelines is poor, and the existing RIGHT Statement cannot be fully suitable for the TCM guidelines. There is a requirement to develop an extension of the RIGHT Statement to reflect the unique characteristics of TCM. In addition, we conducted a comprehensive analysis of the data from the TCM guidelines and condensed the data into initial items. We also used a brainstorming method to supplement the initial items, and we supplemented new items with such discussions to prevent omissions. Moreover, we used the Delphi method and GRADE grid rules in the consensus process. All the participating experts did not know each other, and they answered the questions raised without meeting each other and without discussion. This back-to-back anonymity has advantages and can avoid other influencing factors \[[@bib0100],[@bib0105]\]. Finally, a total of 7 strongly recommended sub-items are determined as extension items into the RIGHT-TCM.

For item 1 (S1 in the checklist of the RIGHT-TCM), it is recommended that a clinical guideline for TCM could be identified by the title. This item is useful for rapid judgment, screening and classification for the TCM guidelines. For item 6 (S2 in the checklist of the RIGHT-TCM), it is recommended to describe the principle and method of TCM treatment in the recommendations section. These general principles and basic methods for treating diseases are based on the unique concept of holism and syndrome differentiation and have guiding significance for the specific treatment measures in traditional Chinese medicine \[[@bib0110]\]. For item 7 (S3 in the checklist of the RIGHT-TCM), it is recommended to describe whether to treat disease based on the syndrome differentiation of TCM. Syndrome differentiation is an important basic concept of TCM \[[@bib0115], [@bib0120], [@bib0125]\]. It is the process of applying "principle-method-recipe-medicines" to clinical practice. For item 8 (S4 in the checklist of the RIGHT-TCM), it is recommended to provide clear and accurate description of TCM decoction in the intervention. TCM decoction refers to a method consisting of herbs with relatively specific processing methods and usage. The decoction is the main prescription of TCM, so it is necessary to make a detailed report on the TCM decoction \[[@bib0130],[@bib0135]\]. For item 8-5 (S4-1 in the checklist of the RIGHT-TCM), it is recommended to describe the administration route and frequency of TCM decoction. The administration route and frequency are also one of the ways to influence the efficacy of the medicine. The traditional administration route of TCM is mainly based on internal and external use (oral and dermatological drugs) \[[@bib0140],[@bib0145]\]. In addition, there are many administration routes such as inhalation, sublingual administration, mucosal surface administration, rectal administration \[[@bib0150]\]. Currently, only 4% and 0.3% of the guidelines describe the route and frequency of administration, respectively. For item 10 (S5 in the checklist of the RIGHT-TCM), it is recommended to provide clear and accurate description of the acupuncture in the intervention. Acupuncture is an important component of TCM interventions. Acupuncture has been increasingly used as an integrative or complementary therapy and it is well-tolerated with little risk of serious adverse effects \[[@bib0155], [@bib0160], [@bib0165], [@bib0170]\]. For item 10-1 (S5-1in the checklist of the RIGHT-TCM), it is recommended to describe the acupuncture points, major points, matching points, and their addition and subtraction information. The acupoint is the area that the Qi in meridian flows into the body surface and is the area where the needle is stabbed \[[@bib0175]\].

After two-round online Delphi consensus, item 8-3 and item 9-1 have been excluded because they have not reached any recommendations. For item 8-3, the composition principle, basis and interpretation of TCM decoction may not the main focus point of the recommendations in the guidelines. For item 9-1, if the TCM guideline describe the product name and manufacturer of traditional Chinese patent medicine, it may involve more interest bias.

With the rapid development in recent years, TCM has been widely used in different area, and its guidelines and handbooks have also played an important role in Public Health Emergency of International Concern (PHEIC) \[[@bib0180]\]. Such as part of \"TCM Classification Therapy to Improve Curative Efficacy\" in the \"Handbook of COVID-19 Prevention and Treatment\" \[[@bib0185]\]. For PHEIC, the procedures and methodological requirements of the Rapid Advice Guideline should be adopted \[[@bib0190], [@bib0195], [@bib0200]\]. However, the current RIGHT-TCM reporting items for the Rapid Advice Guideline has yet to be developed, which may be a possible research direction in the future.

Although this study reflects the scalability of the RIGHT Statement, there are some limitations need to attention. In the current study, we only study the standardized reports of the most commonly TCM interventions, such as TCM decoction, traditional Chinese patent medicine and acupuncture. Interventions of TCM also included moxibustion, massage and cupping, etc. Therefore, we will revise the checklist in the future based on user feedback and evaluation results.

In summary, seven strong recommendation sub-items were added on the basis of RIGHT Statement and formed the RIGHT-TCM finally. We hope that the RIGHT-TCM can assist TCM guideline developers in reporting guidelines and improving the reporting quality, help the target audience understand and implement a guideline.
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